Antifungal susceptibility profile of clinical Alternaria spp. identified by molecular methods.
To analyse the susceptibility pattern of a collection of Alternaria spp. clinical isolates. The antifungal susceptibilities of 35 isolates identified by means of sequencing the internal transcribed spacer region of rDNA were analysed by European Committee on Antimicrobial Susceptibility Testing (EUCAST) methodology. No clear differences among the activity of antifungals against Alternaria alternata and Alternaria infectoria were detected, except for echinocandins.